Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Long-Term Deferred Tax: 2019-2020

  • Silence Therapeutics' Long-Term Deferred Tax rose 6.98% to $33,011 in Q4 2020 from the same period last year, while for Dec 2020 it was $33,011, marking a year-over-year increase of 6.98%. This contributed to the annual value of $32,104 for FY2020, which is 4.76% up from last year.
  • Silence Therapeutics' Long-Term Deferred Tax amounted to $33,011 in Q4 2020, which was up 6.98% from $30,857 recorded in Q4 2019.
  • In the past 5 years, Silence Therapeutics' Long-Term Deferred Tax ranged from a high of $33,011 in Q4 2020 and a low of $30,857 during Q4 2019.
  • For the 2-year period, Silence Therapeutics' Long-Term Deferred Tax averaged around $31,934, with its median value being $31,934 (2019).
  • Data for Silence Therapeutics' Long-Term Deferred Tax shows a peak YoY grew of 6.98% (in 2020) over the last 5 years.
  • Over the past 2 years, Silence Therapeutics' Long-Term Deferred Tax (Quarterly) stood at $30,857 in 2019, then climbed by 6.98% to $33,011 in 2020.